Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VIVO Cannabis Inc. V.PDA


Primary Symbol: VVCIF

VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical locations - Canada, Germany, and Australia.


OTCQB:VVCIF - Post by User

Comment by 1hot-techwomanon Mar 30, 2020 6:24pm
182 Views
Post# 30862052

RE:RE:We are Professionals not Cowboys says Barry Fishman at AGM !

RE:RE:We are Professionals not Cowboys says Barry Fishman at AGM !
1hot-techwoman wrote:
srtman03 wrote: Guess will see......


https://www.vivocannabis.com/press-releases/vivo-cannabis-to-host-conference-call-for-fourth-quarter-2019-results


VIVO's net revenue increased to $6.3 million during Q3 2019, a 19% increase relative to Q2 2019, reflecting the ramp-up of the Company's increased licenced capacity which is expected to result in further revenue growth in Q4 2019



Looks like some decent revenue growth for Q4 !!!

Management Commentary

"During the fourth quarter of 2019, VIVO continued to execute on our strategy, recording revenue growth, sustaining top-tier prices for our premium products, and executing a successful launch of Cannabis 2.0 products," said Barry Fishman , CEO of VIVO. "We have maintained a disciplined and fiscally prudent approach, including taking key actions to navigate through the current COVID-19 pandemic. Going forward, we see several positive catalysts which are expected to deliver profitable growth, including production expansion, distribution channel development, entry into high-growth international markets, and the development and launch of innovative products and services. We are also pleased to be experiencing increased sales in Q1 2020, supported by our medical and Cannabis 2.0 products."

Financial Summary

The Company's gross revenue was $9.5 million for Q4 2019 and $31.8 million for 2019. Net revenue was $6.6 million for Q4 2019, a 5% increase over the previous quarter. Fourth quarter results were positive but were impacted by a considerable allocation of resources to the launch of VIVO's portfolio of Cannabis 2.0 products.


<< Previous
Bullboard Posts
Next >>